This post was originally published on this site

Personalis, Inc. (NASDAQ:PSNL)’s traded shares stood at 388,937 during the last session, with the company’s beta value hitting 0. At the close of trading, the stock’s price was $20.7, to imply an increase of 0.05% or $0.01 in intraday trading. The PSNL share’s 52-week high remains $53.46, putting it -158.26% down since that peak but still an impressive +46.62% since price per share fell to its 52-week low of $11.05. The company has a valuation of $906.04 Million, with an average of 444.43 Million shares in intraday trading volume over the past 10 days and average of 853.13 Million shares over the past 3 months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts have given a consensus recommendation of Buy for Personalis, Inc. (PSNL), translating to a mean rating of 1.8. Of 9 analyst(s) looking at the stock, none analyst(s) give PSNL a Sell rating. None of those analysts rate the stock as Overweight while 1 advise Hold as 8 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.39.

After registering a 0.05% upside in the last session, Personalis, Inc. (PSNL) has traded red over the past five days. The stock hit a weekly high of $23.63 this Friday, May 28, jumping 12.38% in its intraday price action. The 5-day price performance for the stock is -7.01%, and -4.34% over 30 days. Despite these dips, the year-to-date price performance is -43.46%. Short interest in Personalis, Inc. (NASDAQ:PSNL) saw shorts transact 3.08 Million shares and set a 0 days time to cover.

Analysts on Wall Street suggest a consensus price target of $35, implying an increase of 69.08% to the stock’s current value. The extremes give us $28 and $50 for target low and target high price respectively. As such, PSNL has been trading 141.55% off suggested target high and 35.27% from its likely low.

Personalis, Inc. (PSNL) estimates and forecasts

Looking at statistics comparing Personalis, Inc. share performance against respective industry, we note that the company has underperformed competitors. Personalis, Inc. (PSNL) shares are -28.05% down over the last 6 months, with its year-to-date growth rate lower than industry average at -35% against 4.4%. But the analysts are tempering their growth estimates for the 2021 fiscal year. Revenue is forecast to decline -34.5% this quarter before falling -63% for the next one. The rating firms project that company’s revenue will grow 8.4% compared to the previous financial year.

An assessment of the company’s 5-year growth patterns shows that annual earnings fell an estimated 0% for the past 5-year period. While 2021 is set for a 13.8% return in earnings, projections for the next 5 years are at 0% annually.

Personalis, Inc. (NASDAQ:PSNL)’s Major holders

Personalis, Inc. insiders hold 1.64% of total outstanding shares, with institutional holders owning 81.25% of the shares at 82.61% float percentage. In total, 202 institutions holds shares in the company, led by ARK Investment Management, LLC. As of Dec 30, 2020, the company held over 6.78 Million shares (or 15.49% of shares), all amounting to roughly $248.17 Million.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


The next major institution holding the largest number of shares is JP Morgan Chase & Company with 3.34 Million shares, or about 7.63% of shares outstanding. As of the market price on Dec 30, 2020, these shares were worth $122.28 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

We also have ARK ETF Tr-ARK Genomic Revolution ETF and JP Morgan Small Cap Growth Fund as the top two Mutual Funds with the largest holdings of the Personalis, Inc. (PSNL) shares. Going by data provided on Mar 30, 2021, ARK ETF Tr-ARK Genomic Revolution ETF holds roughly 5,667,149 shares. This is just over 12.95% of the total shares, with a market valuation of $139.47 Million. Data from the same date shows that the other fund manager holds a little less at 1.39 Million, or 3.17% of the shares, all valued at about $53.45 Million.